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Abstract
BACKGROUND: Multiply injured patients are at risk of developing hemorrhagic shock and 
organ dysfunction. We determined how cumulative hypoperfusion predicted organ dysfunction by 
integrating serial Shock Index measurements.
METHODS: In this study, we calculated shock volume (SHVL) which is a patient-specific index 
that quantifies cumulative hypoperfusion by integrating abnormally elevated Shock Index (heart 
rate/systolic blood pressure ≥ 0.9) values acutely after injury. Shock volume was calculated at 
three hours (3 hr), six hours (6 hr), and twenty-four hours (24 hr) after injury. Organ dysfunction 
was quantified using Marshall Organ Dysfunction Scores averaged from days 2 through 5 after 
injury (aMODSD2–D5). Logistic regression was used to determine correspondence of 3hrSHVL, 
6hrSHVL, and 24hrSHVL to organ dysfunction. We compared correspondence of SHVL to organ 
dysfunction with traditional indices of shock including the initial base deficit (BD) and the lowest 
pH measurement made in the first 24 hr after injury (minimum pH).
RESULTS: SHVL at all three time intervals demonstrated higher correspondence to organ 
dysfunction (R2 = 0.48 to 0.52) compared to initial BD (R2 = 0.32) and minimum pH (R2 = 0.32). 
Additionally, we compared predictive capabilities of SHVL, initial BD and minimum pH to 
identify patients at risk of developing high-magnitude organ dysfunction by constructing receiver 
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operator characteristic curves. SHVL at six hours and 24 hours had higher area under the curve 
compared to initial BD and minimum pH.
CONCLUSION: SHVL is a non-invasive metric that can predict anticipated organ dysfunction 
and identify patients at risk for high-magnitude organ dysfunction after injury.
LEVEL OF EVIDENCE: Prognostic study, level III.
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Organ dysfunction and adverse outcomes, such as nosocomial infection (NI), affect the 
clinical course of multiple injuries patients (MIPs).1–4 Complications have a significant 
effect on both short-term and long-term outcomes.5,6 Early risk stratification of injury-
related complications would offer treating physicians an expanded window to initiate 
interventional or supportive treatments to improve outcomes.7,8
Hemorrhagic shock (HS) plays a foundational pathophysiologic role in organ dysfunction 
after injury.9–11 Hemorrhagic shock causes immediate reductions in oxygen and nutrient 
delivery accompanied by reduction in waste removal from tissues.12,13 Prolonged HS 
eventually causes tissues to adapt anaerobic energy production which can lead to organ 
dysfunction. The physiologic consequences of HS are directly proportional to the magnitude 
and duration of hypoperfusion.12,13 Therefore, indices that account for both the magnitude 
and duration of HS have potential to stratify risks of complications in MIPs. Traditionally, 
researchers have quantified the magnitude of HS by measuring systemic markers that reflect 
the magnitude of anaerobic metabolism including pH and lactate and by calculating base 
deficit (BD). More recently, researchers have directly measured tissue-level oxygen 
saturation levels as a surrogate of shock.14,15 Collectively, the authors have shown that 
anaerobic metabolism and tissue-level oxygen saturation indices predict outcomes and organ 
dysfunction phenotypes.12,13,16–19 While serum levels of lactate are measured and BD is 
calculated at a single point in time, they reflect temporal accumulation of anaerobic 
metabolic products and accordingly provide insight on the duration and severity of HS. 
However, it is likely that values sampled at a single point in time do not fully account for the 
temporal component of HS and therefore, it remains unknown how well circulating 
concentrations of lactate, BD calculations, and systemic pH levels fully quantify cumulative 
hypoperfusion.
We recently introduced a metric that measures cumulative hypoperfusion, shock volume 
(SHVL).20 Shock volume is calculated by integrating serial Shock Index (SI) (heart rate/
systolic blood pressure) values during any prescribed acute injury/resuscitation time frame. 
Specifically, the duration and magnitude that SI values are above accepted thresholds of 
hypoperfusion (0.9) are integrated into an index that quantifies cumulative hypoperfusion.
16,18,21,22
 The goal of this study was to investigate the clinical utility of SHVL in predicting 
acute outcomes in a prospective cohort of MIPs. Our hypothesis was that SHVL would more 
closely correspond to the magnitude of organ dysfunction in MIPs compared with the 
traditional indices BD and pH. We do not routinely measure lactate at our institution, and 
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therefore lactate was not included in this study for comparison. To test our hypothesis, we 
calculated SHVL and measured BD and pH in a prospective cohort of MIPs and determined 
how these values corresponded to the magnitude of organ dysfunction and how well these 
values identified patients at risk of high-magnitude organ dysfunction.
PATIENTS AND METHODS
Patient Population
This study was approved by our institutional review board (IRB). We enrolled a consecutive 
prospective cohort of 100 blunt MIPs. Patients were aged 18 years to 55 years and met the 
following criteria: (1) presented as a full trauma activation defined by the general surgical 
trauma team with the attending surgeon present at the time of patient intake performing the 
initial resuscitation; (2) were admitted to surgical intensive care unit (ICU) from the 
emergency department or proceeded directly to surgery from the emergency department and 
were then admitted to surgical ICU. We excluded patients who died from traumatic brain 
injuries (TBI) within 48 hours or who had a Glasgow Coma Scale score of 7 or lower at 
presentation with no improvement after 48 hours. In addition, patients with preexisting 
hematologic or immunologic diseases were excluded. A consent waiver for 48 hours was 
allowed by our IRB to circumvent approaching critically injured patients or family members 
during the first 24 hours after injury. In the majority of cases, consent was obtained from a 
legal guardian between 24 hours and 48 hours after injury. If no consent was obtained by 48 
hours after injury, all data were discarded. No patients who were originally enrolled into the 
study by guardian consent withdrew at later follow-up.
SHVL Calculations
Shock volume was calculated by integrating serial SI measurements into a value that 
accounts for both the duration and the magnitude of hypoperfusion during any prescribed 
period (Fig. 1). The SI values above 0.9 indicate hypoperfusion,16,18,21,22 and we chose this 
value as a hypoperfusion threshold for SHVL calculations. In our original work, we 
determined that SHVL calculated with a hypoperfusion threshold of 0.9 correlated more 
closely with organ dysfunction compared with using 1.2 or 1.5 as the threshold value.20 
Therefore, at any time point, the magnitude of hypoperfusion was determined by subtracting 
0.9 from the SI values. For SI values that were less than 0.9, the SI value for SHVL 
calculations was set to zero.
Subsequently, incremental SIi values were determined by averaging the corresponding 
adjacent SI values accounting for the 0.9 threshold. For example, in Figure 1 at time points c 
and d (within the dashed box), the SI values are is 1.1 and 1.5, respectively. The incremental 
SIi value for time interval between points c and d would equal: [(1.1 – 0.9) + (1.5 – 0.9)]/2 = 
0.4.
Incremental SHVLi values were calculated by multiplying the SIi by the duration, in 
minutes, of the corresponding time interval. For example, in Figure 1, if t(d) − t(c) was 15 
minutes, the SHVLi between time points c and d would equal 0.4 × 15 = 6 units of SHVL. 
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Finally, SHVLi values were integrated over an entire prescribed period T to yield a SHVL 
magnitude: SHVL = Σ SHVLi for t = 0 to T.
We calculated three distinct SHVL values during the initial 3 hr, 6 hr, and 24 hr periods (3 hr 
SHVL, 6 hr SHVL, and 24 hr SHVL). These three time points were chosen to quantify 
cumulative hypoperfusion during the initial resuscitation time frame and during the first 
injury day We did not calculate SHVL values beyond 24 hr. The accuracy of SHVL 
measurements is affected by temporal sampling frequency of vital signs.20 In the first 24 hr 
after injury, vital signs were typically recorded every 15 minutes during the first 8 hours to 
12 hours, and rarely greater than a period of 60 minutes. During the second 24 hr after 
injury, vital sign sampling was notably less frequent and therefore we did not calculate 
SHVL beyond the first 24 hr after injury. Organ Dysfunction: The primary outcome was 
organ dysfunction quantified by the Marshall Multiple Organ Dysfunction Score (MODS).23 
The MODS integrates daily integer scores in six organ systems including pulmonary, 
cardiovascular, renal, hepatic, hematologic, and central nervous system. Day 1 (D1) MODS 
more closely reflected the injury magnitude compared with progression of organ dysfunction 
after injury and were not used in organ dysfunction calculations.1,24 We investigated daily 
MODS to develop an optimized index of organ dysfunction. We focused on MODS from D2 
through D5 as this window corresponded to the temporal envelope in which patients either 
resolve injury or develop organ dysfunction.3 In addition, all resuscitative interventions and 
the majority surgical interventions occurred in this period. Individual daily MODS 
(MODSD2; MODSd3, MODSd4, MODSd5) and average MODS (aMODS) representing all 
possible means of combinations of sequential daily scores in D2 through D5 (aMODSD2–D3; 
aMODSD2–D4, aMODSD2–D5; aMODSD3–D4; aMODSD3–D5; aMODSD4–D5) were 
investigated for correspondence to clinical outcomes including duration of admission to 
surgical ICU (ICUDays), duration of mechanical ventilation (MVDays), and the presence of 
NIs.
Nosocomial infections were defined by CDC criteria.25 Pneumonia was diagnosed by (1) the 
presence of a new or progressive radiographic infiltrate; (2) presence of at least two of three 
clinical features, fever (>38°C), leukocytosis (>12 k) or leukopenia (<4 k) and purulent 
secretions; (3) confirmation by quantitative lower respiratory tract cultures via 
brochoalveolar lavage. Bacteremia was defined by clinical symptoms of fever and increased 
cardiac index combined with white blood cell count greater than 12,000 or less than 4,000 
and positive blood cultures. Urinary tract infection was defined by (1) at least one of the 
following signs or symptoms: fever higher than 38°C, suprapubic tenderness, costovertebral 
angle pain or tenderness, urgency, frequency, dysuria; (2) urine culture with no more than 
two species of organisms identified, at least one of which is a bacterium with 100,000 
colony forming units or greater. Nosocomial infections were confirmed by the site principal 
investigator.
Combining MODS from D2 through D5 (aMODSD2–D5) integrated the broadest set of 
information and demonstrated higher correspondence to ICUDays, MVDays, and NI 
compared with individual daily MODS or any other combinations of daily MODS. 
Therefore, aMODSD2–D5 was chosen as our primary outcome for this study.
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Data Analyses
To determine the clinical utility of aMODSD2–D5, initially, we performed logistic regression 
of aMODSD2–D5 with ICUDays and MVDays. These analyses showed progressive increases in 
both ICUDays and MVDays in patients with aMODSD2–D5 of 4 or greater (Fig. 2). 
Accordingly, we defined high-magnitude organ dysfunction as an aMODSD2–D5 of 4 or 
greater and lowmagnitude organ dysfunction as an aMODSD2–D5 less than 4. We compared 
differences in ICUDays, MVDays, and the incidence of NI in patients with an aMODSD2–D5 
either less than 4 or 4 or greater using standard t tests. We further refined our analyses and 
compared differences in ICUDays, MVDays and NI in groups stratified by aMODSD2–D5 from 
0 to less than 2, 2 or greater to less than 4, 4 or greater to less than 6, and 6 or greater with 
standard t tests.
Correspondence of 3 hr SHVL, 6 hr SHVL, and 24 hr SHVL with aMODSD2–D5 was 
determined by logistic regression. Logistic regression was also used to assess 
correspondence of initial BD (notation for BD will remain positive in this manuscript) and 
minimum pH with aMODSD2–D5. Finally, we determined how changes in BD and pH that 
occurred during the initial 24 hours after injury corresponded to organ dysfunction. The 
maximum difference between lowest and highest pH and BD, the difference between the 
initial pH and BD and those obtained 6 hr after injury, and the difference between the initial 
pH and BD and those obtained 24 hr after injury were determined. These delta values 
(differences) were investigated for correspondence to aMODSD2–D5 by logistic regression.
Thresholds of 6 hr SHVL and 24 hr SHVL values identified on regression plots were used to 
construct receiver operator characteristic (ROC) curves to predict high-magnitude organ 
dysfunction. Likewise, ROC curves were also constructed to determine the utility of initial 
BD and minimum pH to predict high-magnitude organ dysfunction. Area under the curve 
(AUC), 95% confidence intervals, sensitivity, specificity, and odds ratios of each index 
threshold are reported for each predictive model.
RESULTS
Patient Population
We prospectively enrolled 100 consecutive MIPs from April of 2015 through September of 
2016, capturing over 95% of eligible patients. The overall mortality for all 100 patients was 
9%. Fifty-one of the 100 patients had TBI. Fifteen of 51 patients were subsequently 
excluded due to severe TBI. In addition, three patients who were initially enrolled were 
subsequently diagnosed with spinal cord injury and were excluded from analysis. One 
additional patient who sustained an iatrogenic air embolus resulting in cardiac arrest and 
death during a transthoracic endovascular aortic repair was removed from analysis. This 
yielded the final study cohort of 81 patients. Six of the nine deaths in the entire 100 patient 
cohort occurred in the 15 patients excluded for severe TBI. The other two deaths occurred in 
the remaining 81 patients for a mortality rate of 2.5% in the final study cohort. 
Demographics, traditional injury severity indices, resource utilization, and global outcomes 
for the final 81 patient cohort are shown in Table 1. In addition, six patients were on 
antihypertensive medications, three patients had diabetes mellitus (one type I and two type 
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II), and four patients had chronic obstructive pulmonary disease. No patients were on 
anticoagulation medicines, or had preexisting cardiac conditions including heart block, or 
had a cardiac pacemaker. All of these patients were included in the study.
Organ Dysfunction and Clinical Indices
There was a clear and abrupt increase in ICUDays (Fig. 2A) and MVDays (Fig. 2B) in patients 
with aMODSD2–D5 of ≥ 4. ICUDays increased from 4.2 (standard deviation (s.d.) = 2.7) days 
in patients with aMODSD2–D5 less than 4 to 15.7 (s.d. = 7.4) days in patients with 
aMODSD2–D5 ≥ 4 (p < 0.0001) (Fig. 3A). Likewise, MVDays increased from 2.2 (s.d. = 2.0) 
days to 11.9 (s.d. = 7.5) days in the same aMODSD–D5 groups (p < 0.0001) (Fig. 3B). 
Finally, NI occurred in 18.8% of patients with aMODSD2–D5 less than 4 compared to 63.6% 
in patients with aMODSD2–D5 greater than 4 (p < 0.0001) (Fig. 3C). There were no 
differences in ICUDays, MVDays, or NI in patients with aMODSD2–D5 of 4 or greater to less 
than 6 compared with patients with aMODSD2–D5 of 6 or greater. These results 
demonstrated that aMODSD2–D5 was a clinically meaningful phenotype which effectively 
delineated lowmagnitude organ dysfunction as aMODSD2–D5 less than 4 and high-
magnitude organ dysfunction as aMODSD2–D5 of 4 or greater.
SHVL Versus Organ Dysfunction
Logistic regression of 3 hr SHVL (R2 = 0.48; p < 0.001), 6 hr SHVL (R2 = 0.52; p < 0.001) 
(Fig. 4A), and 24 hr SHVL (R2 = 0.49; p < 0.001) (Fig. 4B) with aMODSD2–D5 
demonstrated that SHVL values corresponded closely to the magnitude of organ 
dysfunction. Shock volume calculated at all three periods demonstrated higher 
correspondence to aMODSD2–D5 compared with initial BD (R2 = 0.32) (Fig. 4C) and 
minimum pH (R2 = 0.32) (Fig. 4D). In addition, SHVL at all time points demonstrated 
better correspondence with aMODSD2–D5 compared with the maximum delta values of BD 
(R2 = 0.2949) and pH (R2 = 0.2633), the 6 hr delta values of BD (R2 = 0.1499) and pH (R2 = 
0.0752), and the 24 hr delta values of BD (r2 = 0.2897) and pH (R2 = 0.2133). Regression 
plots (Figs. 4A–B) identified thresholds of 6 hr SHVL of 40 and 24 hr SHVL of 70 where 
the incidence of high-magnitude organ dysfunction (aMODSD2–D5 ≥ 4) began to increase 
more rapidly. Similarly, we identified thresholds of initial BD ≥ 6 (Fig. 4C) and a minimum 
pH of ≤ 7.24 (Fig. 4D) as thresholds corresponding to increasing aMODSD2–D5 ≥ 4. 
Therefore, these thresholds were used to construct ROC curves and calculate odds ratios to 
predict patients who would develop high-magnitude organ dysfunction. The ROC curves for 
SHVL indices, initial BD and minimum pH and corresponding AUC, ORs, sensitivity and 
specificity to predict high-magnitude organ dysfunction are shown in Figure 5. Both 6 hr 
SHVL and 24 hr SHVL demonstrated higher AUCs compared with initial BD and minimum 
pH. In addition, 24 hr SHVL was more sensitive than any of the other indices for identifying 
patients at risk for aMODSD2–D5 ≥ 4. In summary, SHVL demonstrated greater 
correspondence with organ dysfunction compared to initial BD, minimum pH, and changes 
in BD and pH occurring during the initial 24 hr. In addition, SHVL more accurately 
identified patients at risk for high-magnitude organ dysfunction compared to initial BD and 
minimum pH.
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SHVL Versus Infection Complications
Twenty-nine (35.8%) of 81 patients developed NI. Mean 3 hr SHVL in patients that 
developed NI was 36.2 (s.d. = 40.1) compared with 19.6 (s.d. = 28.0; p = 0.054) in patients 
who did not develop NI. Mean 6 hr SHVL in patients that developed NI was 59.6 (s.d. = 
55.2) compared to 34.3 (s.d. = 41.1; p = 0.036) in patients who did not develop NI. Finally, 
mean 24 hr SHVL in patients that developed NI was 191.0 (s.d. = 199.9) compared to 107.1 
(s.d. = 124.6; p = 0.047) in patients who did not develop NI. Seven patients developed nine 
surgical site wound infections which included two abdominal wound infections, one chest 
wound infection, and six extremity wound infections. The mean 3 hr SHVL, 6 hr SHVL, and 
24 hr SHVL calculations in patients who developed surgical site wound infections were 58.9 
(s.d. = 41.9), 100.6 (s.d. = 57.2), and 347.1 (s.d. = 251.9). These results demonstrate how 
high levels of cumulative hypoperfusion significantly extrapolate into risk of nosocomial and 
surgical site wound infections.
DISCUSSION
SHVL had increased correspondence with organ dysfunction compared to initial BD and 
minimum pH. In addition, SHVL had increased correspondence to organ dysfunction 
compared to changes in BD and pH that occurred in the first 6 hr to 24 hr after injury. SHVL 
measured at three distinct time intervals, and as early as three hours after injury, numerically 
accounted for nearly 50% of observed organ dysfunction (R2 = 0.48 to 0.52; Figs. 4A–B). 
SHVL accounts for the entire time-magnitude hypoperfusion history specific to the 
individual patient within a prescribed period. For example, the 24 hr SHVL was informed by 
the entire SI data set in the initial 24 hr after injury and demonstrated the highest sensitivity 
and odds ratio of identifying patients at risk for high-magnitude (aMODSD2–D5 ≥ 4) organ 
dysfunction. However, the 24 hr SHVL and 6 hr SHVL had effectively identical 
correspondence with the magnitude of organ dysfunction (Figs. 4A and B) and AUC indices 
for predicting patients who developed high-magnitude organ dysfunction. These 
observations likely reflect that the majority of patients in HS were successfully resuscitated 
within six hours after injury. The modest increases in sensitivity and odds ratio demonstrated 
by 24 hr SHVL for predicting high-magnitude organ dysfunction are consistent with clinical 
observations that patients who have occult hypoperfusion persisting 24 hr after injury are at 
risk for organ dysfunction, complications, and death.26–28 It is possible that the higher 
correspondence between SHVL and organ dysfunction compared with all of the measures of 
BD and pH reflects that SHVL is informed by a complete temporal set of data that accounts 
for the entire hypoperfusion history.
We did not compare SHVL with lactate only because we do not routinely measure lactate in 
our hospital. It is possible that lactate would have better correspondence to organ 
dysfunction, and lactate thresholds may have better predicted high-magnitude organ 
dysfunction compared with BD and pH measurements and any of the SHVL calculations. 
However, it is possible that circulating lactate serum values would parallel BD and pH 
measurements, and correspondence between lactate and organ dysfunction would be similar 
to correspondence of aMODSD2–D5 with initial BD and minimum pH. Therefore, we cannot 
conclude that SHVL is a superior index to predict organ dysfunction compared with lactate.
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Shock volume calculations would presumably be affected by preinjury demographics, 
hemorrhage severity, patient response to injury, and resuscitation interventions. During the 
study period, we used the same resuscitation strategy of two units of PRBCs: one unit of 
FFP for patients who received blood products. Our hospital has since evolved after the 
conclusion of this study to the 1:1:1 protocol of PRBCs: FFP: Platelets. Differences in 
response to resuscitation interventions would invariably be reflected in both the magnitude 
and rate of change of SHVL. However, we did not specifically account for changes in SHVL 
(or BD and pH) pertaining to individual resuscitation measures in this study. Therefore, it is 
not known if SHVL is an effective metric to judge resuscitation. In addition, our study 
population age bracket was purposely narrowed in an attempt to minimize confounding 
effects of preexisting medical comorbidities. Therefore, it is unknown how SHVL 
corresponds to organ dysfunction in patients older than 55 years or in patients with medical 
comorbidities particularly pertaining to cardiac disease. Finally, we studied trauma patients 
who were initially admitted to ICU, representing a bias toward more seriously injured 
patients. It remains unknown how SHVL risk-stratifies organ dysfunction in patients who 
were less injured and not initially admitted to a higher level of care.
The primary objective of this investigation was to determine if SHVL could accurately 
predict the magnitude of organ dysfunction. Therefore, it was important to quantify organ 
dysfunction using methods that were clinically relevant. Researchers have debated optimal 
organ dysfunction phenotypes for experiments similar to our study.1,4,5,10 There are multiple 
scoring systems that quantify organ dysfunction that are notably similar. Therefore, instead 
of comparing how SHVL, BD, and pH corresponded to organ dysfunction using different 
organ scoring systems, we adapted an alternative approach that integrated progression of 
daily MODS to investigate a temporally expanded signature of organ dysfunction. We chose 
to investigate MODS from D2 through D5 which is admittedly arbitrary, but this 
corresponded to the period in which resuscitation was completed and the majority of 
surgical interventions occurred. In addition, it corresponded to a timeframe in which nearly 
all patients either resolved their injuries or developed longer-term illness with prolonged 
admission to ICU, consistent with previous investigations.3,10,23,29 This approach identified 
a markedly stark cutoff value of aMODSD2–D5 of 4 (Fig. 2) which delineated patients into 
groups of benign or complicated outcomes (Fig. 3). Patients who had an aMODSD2–D5 of < 
4 had little morbidity and resource utilization. In contrast, patients with an aMODSD2–D5 ≥ 4 
had significant increases in NI, ICUDays and MVDays. These data suggest that not only is 
aMODSD2–D5 a meaningful phenotype of organ dysfunction, but this index could serve as a 
therapeutic endpoint to judge efficacy of resuscitative, surgical and supportive interventions 
in MIPs. Additionally, indices such as SHVL calculations that identify patients at risk of 
developing an aMODSD2–D5 ≥ 4 could alert clinicians early in the injury course and expand 
treatment windows to optimize surgical and supportive interventions. Finally, SHVL can be 
calculated in real time without any invasive monitoring or laboratory facilities. It may be 
particularly applicable for austere conditions, such as forward echelons in military care (i.e., 
Role 2 facilities) to titrate evacuation decisions. Alternatively, software adaptations to 
standard vital sign monitoring can readily calculate and display changes in SHVL in real 
time on any standard ICU monitor. Ongoing changes in real-time SHVL measurements 
could be readily available to alert physicians and nursing personnel that patients are not 
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adequately resuscitated, or may be reverting back into HS after initial successful 
resuscitation. However, rigorous prospective investigation will be necessary to determine the 
clinical utility of SHVL.
Traditionally, multiple organ failure (MOF) using MODS has been defined as two 
consecutive days of a MODS greater than 5.30 Therefore, MOF was present in 24 (29.6%) of 
81 patients in this cohort. Twenty-three of 24 patients who were positive for MOF30 in this 
series had high-magnitude organ dysfunction with an aMODSD2–D5 of 4 or greater. In 
contrast, there were 9 (15.8%) of 57 patients who did not meet criteria for MOF that had 
high-magnitude organ dysfunction with an aMODSD2–D5 of 4 or greater. In these nine 
patients, six (66.7%) developed NI, mean ICUDays was 15.1 (7 to 31) days, and mean 
MVDays was 13.2 (5 to 31) days. In this small sample of patients, this suggests that 
integrating organ dysfunction information over an expanded window better reflects clinical 
outcomes compared to the traditional definition of MOF by the Marshall Score criteria.
Shock volume accuracy is dependent on vital sign sampling frequency and accuracy of SIi 
values. In patients with prolonged time between vital sign recordings, an aberrantly high or 
low SI value measured at the beginning or the end of the prolonged interval would be 
multiplied by a large time increment and inadvertently increase or decrease the SHVLi 
calculation. In addition, inaccurate SI values would inadvertently affect the preceding and 
the subsequent SHVLi calculations. For example, in a patient with a SBP of 100 and a 
prevailing HR of 80, the SIi would be 0.8, and this measurement would minimize the two 
corresponding SHVLi calculations. If the same patient’s HR was transiently increased to 140 
secondary to pain or an ICU-based intervention, the SIi would increase to 1.4 and this would 
significantly increase both corresponding SHVLi- calculations. Finally, SHVL calculations 
assume that the SI threshold of 0.9 indicates hypoperfusion. Shock Index has been shown to 
predict mortality, transfusion requirements, and organ dysfunction, and has been shown to be 
equally as accurate as BD in predicting transfusion requirements.18,22 A recent review and 
meta-analysis have concluded that an SI of 0.9 was the best threshold for hypoperfusion.
18,21,22
In conclusion, SHVL is a measure of cumulative hypoperfusion generated from serial vital 
sign measurements. It is an effective tool that can predict the magnitude of anticipated organ 
dysfunction and stratify the risk of developing high-magnitude organ dysfunction in MIPs.
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Figure 1. 
Schematic depicting SHVL calculations. Five SI values (small black diamonds) are shown at 
five corresponding time points a through e (time points designated t(a), t(b), …). Four 
distinct incremental SHVLi segments (SHVLa–b, SHVLb–c, SHVLc–d, and SHVLd–e) are 
depicted between time points a through e. The mean incremental SIi value (above the 0.9 
hypoperfusion threshold depicted by the dashed line) between time points c and d is 
illustrated by the large diamond within the dashed box. It is the average of the adjacent SI 
values, SIc and SId. This SIi value is multiplied by the time duration of the interval t (t = t(d) 
– t(c) in minutes) to yield the incremental SHVLc–d value. For the prescribed time interval 
from 0 to T, all of the incremental SHVLi are summed to yield the SHVL. For example, for 
the 3 hr SHVL, all incremental SHVLi from admission until 3 hr after admission would be 
summed. In this figure, SHVL would include all SHVLi from 0 to T.
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Figure 2. 
Scatterplots demonstrate a marked increase in ICUDays (A) and MVDays (B) in patients who 
had an aMODSD2–D5 ≥ 4. Note the patient in the dashed box died on hospital day 5.
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Figure 3. 
Clinical indices demonstrated marked increases in duration of admission to intensive care 
(A), duration of mechanical ventilation (B), and the incidence of NIs (C) in patients with an 
aMODSD2–D5 ≥ 4. Horizontal bars demonstrate differences considered statistically 
significant (p < 0.05) by t-testing.
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Figure 4. 
Shock volume calculated at 6 hr (A) and 24 hr (B) demonstrated excellent correspondence to 
organ dysfunction (aMODSD2–D5) with R2 values from 0.49 to 0.52. Correspondence 
between SHVL and aMODSD2–D5 was greater than that seen with initial BD (C) and 
minimum pH (D). 3hrSHVL (data not shown) had similar correspondence with 
aMODSD2–D5 compared with 6hrSHVL and 24hrSHVL with an R2 = 0.48.
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Figure 5. 
ROC curves comparing how 6hrSHVL and 24hrSHVL (top row) and initial BD and 
minimum pH (bottom row) predict patients who will develop high-magnitude organ 
dysfunction defined as aMODSD2–D5 ≥ 4. AUC (upper confidence limit, lower confidence 
limit), odds ratio (OR; upper confidence limit, lower confidence limit), and sensitivity/
specificity are displayed. 24hrSHVL demonstrated the highest predictive power of high-
magnitude organ dysfunction.
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TABLE 1.
Cohort Demographics, Injury Severity and Resource Utilization
Age 36.5 (± 11.4) y
Sex 60 Male/21 Female
Injury Severity Score 31.3 (± 14.1)
Initial BD 6.1 (± 4.5)
Minimum pH 7.23 (± 0.10)
ICUDays 8.8 (± 7.6) d
MVDays 6.1 (± 6.9) d
Mortality 2/81 (2.5%)
MOF 24/81 (29.8%)
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